(a) Results from univariate analyses
| ALZ or CLA | 0.27 (0.06, 1.28) |
. | . | . | 1.29 (0.24, 6.90) |
1.07 (0.41, 2.80) |
. |
|---|---|---|---|---|---|---|---|
| 0.83 (0.30, 2.27) |
Anti-CD20 agents | 3.11 (0.75, 12.94) |
2.56 (0.91, 7.20) |
0.70 (0.17, 2.98) |
2.86
(1.21, 6.77) |
1.32 (0.84, 2.07) |
0.77 (0.18, 3.24) |
| 2.40 (0.43, 13.3) |
2.90 (0.70, 12.03) |
DMF | 0.82 (0.15, 4.52) |
0.23 (0.03, 1.64) |
1.33 (0.19, 9.47) |
0.55 (0.13, 2.43) |
0.25 (0.03, 1.78) |
| 1.71 (0.51, 5.69) |
2.07 (0.94, 4.54) |
0.71 (0.15, 3.45) |
FNG | 0.28 (0.05, 1.53) |
1.61 (0.29, 8.84) |
0.74 (0.34, 1.60) |
0.30 (0.05, 1.66) |
| 0.62 (0.17, 2.17) |
0.74 (0.31, 1.82) |
0.26 (0.05, 1.32) |
0.36 (0.12, 1.08) |
NTZ | 5.85 (0.81, 42.25) |
1.97 (0.85, 4.56) |
1.09 (0.15, 7.94) |
| 2.62 (0.77, 8.83) |
3.17
(1.38, 7.25) |
1.09 (0.22, 5.47) |
1.53 (0.52, 4.50) |
4.25
(1.34, 13.46) |
No DMT |
0.39
(0.17, 0.92) |
0.19 (0.03, 1.34) |
| 1.17 (0.45, 3.02) |
1.41 (0.92, 2.17) |
0.49 (0.11, 2.06) |
0.68 (0.32, 1.45) |
1.90 (0.82, 4.38) |
0.45 (0.19, 1.02) |
Platform therapy | 0.45 (0.10, 1.99) |
| 0.59 (0.11, 3.33) |
0.72 (0.17, 3.01) |
0.25 (0.03, 1.78) |
0.35 (0.07, 1.70) |
0.96 (0.19, 5.00) |
0.23 (0.04, 1.15) |
0.51 (0.12, 2.18) |
TRF |